BRISTOL-MYERS SQUIBB CO.
Clinical trial NCT02270814 updates: 1. completion date: 2026-06-30 → 2026-09-30 2. primary completion date: 2026-06-30 → 2026-09-30
Clinical trial NCT02270814 updates: 1. completion date: 2026-06-30 → 2026-09-30 2. primary completion date: 2026-06-30 → 2026-09-30
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical